by Michael Nevradakis, Ph.D., Childrens Health Defense: During three days of meetings last week, advisers to the Centers for Disease Control and Prevention last week voted unanimously in favor of recommending Pfizer’s new 20-valent pneumococcal conjugate vaccine — currently administered only to adults — as an “option” for children. Advisers to the Centers for Disease […]
Source